$FGEN insider sales

Insider sales at Fibrogen Inc.

Chief Medical Officer -$145,401
Dir -$1,298,000
CEO -$1,996,274

Check out all pharma insider sales in our SeekingAlpha Marketplace Daily Pharma Scoop.

$NLNK target raised nearly 300%

Jefferies Group Upgrades NewLink Genetics Corporation (NLNK) Hold -> Buy raising target $7.00 -> $26.00.
Robert W. Baird also Upgrades NLNK Neutral -> Outperform raising target $8.00 -> $22.00.
Cantor Fitzgerald Reiterates Overweight with target of $26.00.

Check out more ratings and analysis on our SeekingAlpha Marketplace Daily Pharma Scoop.

Morgan Stanley Downgrades $MNK

Morgan Stanley Downgrades Mallinckrodt PLC (MNK) from Overweight -> Equal Weight reducing target $65.00 -> $40.00, while Piper Jaffray, Stifel Nicolaus, Mizuho, Cantor Fitzgerald reiterate BUY with targets ranging from $52 to $85.

Get in-depth analysis in our Daily Pharma Scoop at SeekingAlpha Marketplace.

$INSM gets wide coverage

Stifel Nicolaus Reiterates Buy target raised $27.00 -> $43.00
Robert W. Baird Reiterates Outperform -> Positive raising target $23.00 -> $32.00
Cowen and Company Reiterates Outperform with target $54.00
HC Wainwright Reiterates Buy with target $35.00
Evercore ISI Raises Target from $28.00 -> $40.00 with Outperform rating
Leerink Swann Raises Target 1$27.00 -> $36.00 with Outperform rating

Get in-depth analysis in our Daily Pharma Scoop at SeekingAlpha Marketplace.

Target raised on $HALO

Deutsche Bank AG Raises Target on Halozyme Therapeutics (HALO) to $20 with Buy rating.
BMO Capital Markets Raises Target from $14.00 -> $15.00 with Market Perform rating.

Check our detailed coverage on HALO at our SeekingAlpha Marketplace page.

$BMY gets varied coverage

BMO Capital Markets Reiterates Sell on BMY at $49.00.
Credit Suisse Group Reiterates Neutral -> Hold.
Goldman Sachs Reiterates Buy with target $62.00 -> $65.00.

Get in-depth analysis in our Daily Pharma Scoop at SeekingAlpha Marketplace.

J P Morgan upgrades $BCRX

J P Morgan Chase & Co Upgrades BioCryst Pharmaceuticals (BCRX) from Neutral to Overweight with target raised from $6 to $9.

Check out more ratings on our SeekingAlpha Marketplace Daily Pharma Scoop.

Target raised on $AVDL

Langenberg & Company Reiterates Buy target $27.00 -> $30.00
Ladenburg Thalmann Raises Target $27.00 -> $30.00

Check out more ratings on our SeekingAlpha Marketplace page.

$ALNY covered widely

Instinet reduces target to $56.00
Leerink Swann Reiterates Market Perform with target $83.00 -> $72.00
Needham & Company Reiterates Buy - $98.00 -> $85.00
Barclays Reiterates Equal Weight -> Overweight with target $80.00 -> $105.00
Piper Jaffray Reiterates Overweight at $126.00 -> $110.00

Check out more ratings on our SeekingAlpha Marketplace page.

Piper Jaffray reiterates buy on $ABBV

Piper Jaffray reiterates buy on $ABBV with price target of $100.

Check out more ratings on our SeekingAlpha Marketplace page.